[Microbiological and therapeutic considerations of Acinetobacter spp. infection].
López-Brea
M
M
Servicio de Microbiología, Hospital Universitario de la Princesa, Diego de León 62, 28006 Madrid, Spain.
Alarcón
T
T
López
S
S
D000150:Acinetobacter / Q000145:classification / Q000187:drug effects / Q000201:enzymology / Q000302:isolation & purification; D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000382:microbiology*; D000900:Anti-Bacterial Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D001618:beta-Lactamases / Q000187:drug effects; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D001618:beta-Lactamases